Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Dow
Federal Trade Commission
McKesson
Farmers Insurance
US Department of Justice
Colorcon
Boehringer Ingelheim
Cantor Fitzgerald

Generated: October 19, 2017

DrugPatentWatch Database Preview

THORAZINE Drug Profile

« Back to Dashboard

What is the patent landscape for Thorazine, and what generic Thorazine alternatives are available?

Thorazine is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in THORAZINE is chlorpromazine. There are twenty drug master file entries for this compound. Additional details are available on the chlorpromazine profile page.

Summary for Tradename: THORAZINE

US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list38
Clinical Trials: see list2
Patent Applications: see list6,075
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:THORAZINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL011120-016Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
CONCENTRATE;ORAL009149-043Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL011120-019Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
TABLET;ORAL009149-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
INJECTABLE;INJECTION009149-011Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
TABLET;ORAL009149-020Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
TABLET;ORAL009149-013Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL011120-017Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL011120-018Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
THORAZINE
chlorpromazine hydrochloride
CONCENTRATE;ORAL009149-032Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Fuji
US Army
McKesson
AstraZeneca
Chubb
Cerilliant
Teva
Federal Trade Commission
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot